These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1707101)
21. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret. Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289 [TBL] [Abstract][Full Text] [Related]
22. Mechanisms by which cancer chemotherapeutic drugs induce emesis. Cubeddu LX Semin Oncol; 1992 Dec; 19(6 Suppl 15):2-13. PubMed ID: 1485177 [TBL] [Abstract][Full Text] [Related]
23. The role of serotonin as a mediator of emesis induced by different stimuli. du Bois A; Kriesinger-Schroeder H; Meerpohl HG Support Care Cancer; 1995 Sep; 3(5):285-90. PubMed ID: 8520873 [TBL] [Abstract][Full Text] [Related]
25. The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets. Tattersall FD; Rycroft W; Cumberbatch M; Mason G; Tye S; Williamson DJ; Hale JJ; Mills SG; Finke PE; MacCoss M; Sadowski S; Ber E; Cascieri M; Hill RG; MacIntyre DE; Hargreaves RJ Neuropharmacology; 2000 Feb; 39(4):652-63. PubMed ID: 10728886 [TBL] [Abstract][Full Text] [Related]
26. Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model. Endo T; Hamaue N; Ihira E; Teramoto Y; Liu Y; Hirafuji M; Minami M Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):55-68. PubMed ID: 14632314 [TBL] [Abstract][Full Text] [Related]
27. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret. Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904 [TBL] [Abstract][Full Text] [Related]
28. Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates. Ullah I; Subhan F; Ayaz M; Shah R; Ali G; Haq IU; Ullah S BMC Complement Altern Med; 2015 Feb; 15():34. PubMed ID: 25888212 [TBL] [Abstract][Full Text] [Related]
29. Reduced normogastric electrical activity associated with emesis: a telemetric study in ferrets. Percie du Sert N; Chu KM; Wai MK; Rudd JA; Andrews PL World J Gastroenterol; 2009 Dec; 15(48):6034-43. PubMed ID: 20027675 [TBL] [Abstract][Full Text] [Related]
30. Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy. Cubeddu LX; O'Connor DT; Parmer RJ J Clin Oncol; 1995 Mar; 13(3):681-7. PubMed ID: 7533826 [TBL] [Abstract][Full Text] [Related]
31. The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. Tattersall FD; Rycroft W; Hargreaves RJ; Hill RG Eur J Pharmacol; 1993 Nov; 250(1):R5-6. PubMed ID: 8119305 [TBL] [Abstract][Full Text] [Related]
32. Antiemetic activity of butorphanol against cisplatin-induced emesis in ferrets and dogs. Schurig JE; Florczyk AP; Rose WC; Bradner WT Cancer Treat Rep; 1982 Oct; 66(10):1831-5. PubMed ID: 6889914 [TBL] [Abstract][Full Text] [Related]
33. Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets. Endo T; Ogawa T; Hamaue N; Akita K; Hirafuji M; Minami M; Blower PR Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):243-53. PubMed ID: 9730004 [TBL] [Abstract][Full Text] [Related]
34. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret. Lau AH; Kan KK; Lai HW; Ngan MP; Rudd JA; Wai MK; Yew DT Eur J Pharmacol; 2005 Jan; 506(3):241-7. PubMed ID: 15627434 [TBL] [Abstract][Full Text] [Related]
35. Insights into the central pathways involved in the emetic and behavioural responses to exendin-4 in the ferret. Lu Z; Yeung CK; Lin G; Yew DT; Andrews PL; Rudd JA Auton Neurosci; 2017 Jan; 202():122-135. PubMed ID: 27692857 [TBL] [Abstract][Full Text] [Related]
36. Antiemetic effect of a potent and selective neurokinin-1 receptor antagonist, FK886, on cisplatin-induced acute and delayed emesis in ferrets. Furukawa TY; Nakayama H; Imazumi K; Yamakuni H; Takeshita K; Matsuo M; Manda T; Uchida W Biol Pharm Bull; 2014; 37(2):232-8. PubMed ID: 24492720 [TBL] [Abstract][Full Text] [Related]
37. The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret. Percie du Sert N; Rudd JA; Moss R; Andrews PL Neurosci Lett; 2009 Nov; 465(1):16-20. PubMed ID: 19733218 [TBL] [Abstract][Full Text] [Related]
38. Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret. Sam TS; Kan KK; Ngan MP; Rudd JA; Yeung JH Eur J Pharmacol; 2003 Apr; 466(1-2):163-8. PubMed ID: 12679153 [TBL] [Abstract][Full Text] [Related]
39. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist. Ozaki A; Sukamoto T Gen Pharmacol; 1999 Sep; 33(3):283-8. PubMed ID: 10480662 [TBL] [Abstract][Full Text] [Related]
40. Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret. Sam TS; Ngan MP; Riendeau D; Robichaud A; Rudd JA J Pharmacol Sci; 2007 Feb; 103(2):189-200. PubMed ID: 17310074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]